On this page
In short What it costs without insurance The generic is already here If you have Medicare If you have commercial insurance If you have no coverage Common questions SourcesAstraZeneca lists Farxiga (dapagliflozin) at $377.82 for a 30-day supply as of January 1, 2026, but a generic is already here: FDA-approved since April 2026 and sold from about $7 for 30 tablets at Cost Plus Drugs to about $272 elsewhere. Medicare's negotiated maximum fair price took effect January 1, 2026, eligible commercially insured patients may pay as little as $0 a month with the savings card, and AstraZeneca sells brand Farxiga direct to eligible patients for $35 for 30 tablets. What you pay depends on your coverage, pharmacy and eligibility.
What it costs without insurance
Farxiga is used for type 2 diabetes, heart failure and chronic kidney disease and is taken once a day, so 30 tablets make a typical one-month supply. AstraZeneca lists the price of brand Farxiga at $377.82 for a 30-day supply as of January 1, 2026, while noting that the list price may not reflect what you pay. Pharmacies set their own cash prices, which vary by strength, quantity and ZIP code, so comparing two or three pharmacies before each refill can be real money. AstraZeneca's published averages, based on IQVIA data for the 12 months ending April 2023, put the average out-of-pocket cost at $25.54 a month for people with commercial insurance and $38.82 a month for people with Medicare Part D.
The generic is already here
Generic dapagliflozin has been FDA-approved since April 6, 2026 in both 5 mg and 10 mg strengths from multiple manufacturers, according to Drugs.com, and it is genuinely available: AstraZeneca itself cites broad generic availability as the reason it is winding down its patient assistance program for brand Farxiga. Prices vary widely by pharmacy. When we checked on October 28, 2026, Mark Cuban Cost Plus Drug Company had both strengths in stock at $7.07 to $12.28 for a 30- to 90-tablet supply including its pharmacy fee, before shipping, while Drugs.com listed generic dapagliflozin at about $272 for 30 tablets. Ask a licensed US pharmacist which generic they stock and what it costs.
If you have Medicare
Two 2026 changes matter here. First, Farxiga was in the first group of drugs with a Medicare negotiated price: CMS set a negotiated maximum fair price of $178.50 per 30-day supply, 68% below the $556 reference price, effective January 1, 2026, and CMS counts about 994,000 Part D enrollees who used Farxiga in 2023. That price is not a guaranteed patient co-pay; your Part D plan determines what you owe. Second, Part D now caps your total out-of-pocket drug spending at $2,100 for the year across all covered Part D drugs, excluding premiums. Our guides to the 2026 Part D changes and Medicare Savings Programs and Extra Help walk through both.
If you have commercial insurance
The Farxiga savings card lets eligible commercially insured patients pay as little as $0 per 30-day supply, with maximum savings of $175 per 30-day supply, according to the published terms we checked on October 28, 2026. The card is not available for patients enrolled in a government program such as Medicare, Medicaid, Medigap, VA, Department of Defense programs or TRICARE, even if they choose to pay cash. Cash-paying patients can have AstraZeneca pay the first $150 of each monthly prescription and cover the rest themselves. The offer is limited to US and Puerto Rico residents aged 18 and over, other restrictions apply, and AstraZeneca can change or end the offer at any time, so confirm the current terms before counting on the price.
If you have no coverage
If you have no prescription coverage, start with the generic: comparing pharmacies can mean the difference between roughly $7 and roughly $272 for the same 30 tablets, based on the Cost Plus Drugs and Drugs.com listings we checked on October 28, 2026. If you need the brand, AstraZeneca sells Farxiga directly to eligible patients for $35 for 30 tablets through AstraZeneca Patient Direct, and the savings card pays the first $150 of a cash prescription. One assistance route has closed: the AZ&Me Prescription Savings Program stopped accepting new Farxiga patients on May 1, 2026, and will end Farxiga support for current enrollees on December 31, 2026, citing broad generic availability. Do not stop or ration diabetes, heart failure or kidney medication on your own. If cost may make you skip doses, contact your prescriber or pharmacist before you run out. Our guides to affording medication and patient assistance programs list more routes.
Common questions
Is there a generic version of Farxiga?
Yes. The FDA approved generic dapagliflozin on April 6, 2026 in 5 mg and 10 mg strengths from multiple manufacturers, according to Drugs.com, and generics are stocked by pharmacies such as Mark Cuban Cost Plus Drug Company, which listed a 30-tablet supply at about $7 including its pharmacy fee, before shipping, when we checked on October 28, 2026.
How much is Farxiga per month without insurance?
AstraZeneca's list price for brand Farxiga is $377.82 for a 30-day supply as of January 1, 2026. Cash prices vary widely by pharmacy: generic dapagliflozin listings ranged from about $7 at Cost Plus Drugs to about $272 at the pharmacies Drugs.com aggregates, checked October 28, 2026.
Can I get Farxiga for free or nearly free?
AstraZeneca sells brand Farxiga directly to eligible patients for $35 for 30 tablets through AstraZeneca Patient Direct, and eligible commercially insured patients can pay as little as $0 per 30-day supply with the Farxiga savings card. The AZ&Me patient assistance program stopped accepting new Farxiga patients on May 1, 2026, and ends Farxiga support for existing enrollees on December 31, 2026, citing broad generic availability.
Can Pymander help with Farxiga costs?
Pymander can explain your coverage options, assistance programs and questions to ask your doctor or pharmacist. It is not a pharmacy and does not sell or fill medication.